← back to search

Lebing Yang

Wenzhou University · CN
Area of research
Molecular Biology · Biomedical Engineering
Research interest
Research interests include Epigenetics and DNA Methylation, Mechanical Circulatory Support Devices, RNA Interference and Gene Delivery, and Extracellular vesicles in disease.
h-index
2
citations
328
works
2
NIH funding
primary concept
email

Recent publications

Loss of m6A demethylase ALKBH5 promotes post‐ischemic angiogenesis via post‐transcriptional stabilization of WNT5A
Clinical and Translational Medicine 2021cited by 179position: middledoi
Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment
Biomaterials 2021cited by 149position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jingjing Hu · Nanchang University2 papers (2021–2021)Yongchao Zhao · Zhejiang Chinese Medical University2 papers (2021–2021)Kun Yang · Fujian Medical University2 papers (2021–2021)Aijun Sun · Shanghai Medical College of Fudan University1 papers (2021–2021)Lingqiu Kong · Heart Rhythm Society1 papers (2021–2021)Chaofu Li · Fourth Affiliated Hospital of Guangxi Medical University1 papers (2021–2021)Yong Yin · China Pharmaceutical University1 papers (2021–2021)Biao Xu · Nanjing University of Chinese Medicine1 papers (2021–2021)Xiaolei Sun · Qingdao University1 papers (2021–2021)Bei Shi · Zunyi Medical University1 papers (2021–2021)Zilun Wei · Nanjing Drum Tower Hospital1 papers (2021–2021)Beijian Zhang · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2021–2021)Junbo Ge · Sun Yat-sen University1 papers (2021–2021)Shuai Song · Shenyang Pharmaceutical University1 papers (2021–2021)Zhaoyang Chen · Guangzhou University of Chinese Medicine1 papers (2021–2021)Junbo Ge · Tsinghua University1 papers (2021–2021)Fuhai Li · Washington University in St. Louis1 papers (2021–2021)Weidong Xiong · Wuhan University1 papers (2021–2021)Kai Hu · Fudan University1 papers (2021–2021)